Wells Fargo & Company Apollo Endosurgery, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$9.83 - $9.96 $275 - $278	-28 Reduced 10.61%	236 $2,000
Q4 2022 Feb 13, 2023	BUY	$5.91 - $10.14 $70 - $121	12 Added 4.76%	264 $2,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.74 $153 - $283	42 Added 20.0%	252 $1,000
Q2 2022 Aug 12, 2022	BUY	$3.65 - $6.04 $73 - $120	20 Added 10.53%	210 $1,000
Q1 2022 May 16, 2022	BUY	$5.01 - $8.77 $30 - $52	6 Added 3.26%	190 $1,000
Q4 2021 Feb 14, 2022	BUY	$7.64 - $10.11 $458 - $606	60 Added 48.39%	184 $2,000
Q3 2021 Nov 15, 2021	BUY	$7.35 - $9.93 $279 - $377	38 Added 44.19%	124 $1,000
Q2 2021 Aug 16, 2021	BUY	$5.37 - $8.95 $10 - $17	2 Added 2.38%	86 $1,000
Q4 2020 Feb 09, 2021	BUY	$1.66 - $4.81 $31 - $91	19 Added 29.23%	84 $0
Q3 2020 Nov 05, 2020	SELL	$1.27 - $1.88 $22 - $33	-18 Reduced 21.69%	65 $0
Q1 2020 May 14, 2020	BUY	$1.27 - $3.19 $105 - $264	83 New	83 $0

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.